General Information of the Compound
| Compound ID |
CP0373800
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(2-phenoxyphenyl)piperazine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(2-Phenoxy-phenyl)-piperazine
1-(2-phenoxyphenyl)piperazine
BDBM50299785
CHEMBL573532
SCHEMBL546735
VAXHGPCUAFNAQS-UHFFFAOYSA-N
ZINC37635596
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H18N2O
|
||||||||||||||||||
| Molecular Weight |
254.333
|
||||||||||||||||||
| Canonical SMILES |
C1CN(CCN1)c1ccccc1Oc1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H18N2O/c1-2-6-14(7-3-1)19-16-9-5-4-8-15(16)18-12-10-17-11-13-18/h1-9,17H,10-13H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
VAXHGPCUAFNAQS-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound